Cargando…

Vitamin D and Disease Severity in Multiple Sclerosis—Baseline Data From the Randomized Controlled Trial (EVIDIMS)

Objective: To investigate the associations between hypovitaminosis D and disease activity in a cohort of relapsing remitting multiple sclerosis (RRMS) and clinically isolated syndrome (CIS) patients. Methods: In 51 RRMS and 2 CIS patients on stable interferon-β-1b (IFN-β-1b) treatment recruited to t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bäcker-Koduah, Priscilla, Bellmann-Strobl, Judith, Scheel, Michael, Wuerfel, Jens, Wernecke, Klaus-Dieter, Dörr, Jan, Brandt, Alexander Ulrich, Paul, Friedemann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052055/ https://www.ncbi.nlm.nih.gov/pubmed/32158426 http://dx.doi.org/10.3389/fneur.2020.00129

Ejemplares similares

High-dose vitamin D supplementation in multiple sclerosis – results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trial
por: Dörr, Jan, et al.
Publicado: (2020)

Effect of vitamin D supplementation on N‐glycan branching and cellular immunophenotypes in MS
por: Bäcker‐Koduah, Priscilla, et al.
Publicado: (2020)

Disease Modification in Multiple Sclerosis by Flupirtine—Results of a Randomized Placebo Controlled Phase II Trial
por: Dörr, Jan, et al.
Publicado: (2018)

Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial
por: Dörr, Jan, et al.
Publicado: (2012)

Association of Retinal and Macular Damage with Brain Atrophy in Multiple Sclerosis
por: Dörr, Jan, et al.
Publicado: (2011)

Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis
por: Paul, Friedemann, et al.
Publicado: (2008)

Epigallocatechin Gallate in Progressive MS: A Randomized, Placebo-Controlled Trial
por: Rust, Rebekka, et al.
Publicado: (2021)

Standardization of T1w/T2w Ratio Improves Detection of Tissue Damage in Multiple Sclerosis
por: Cooper, Graham, et al.
Publicado: (2019)

Retinal Thickness Analysis in Progressive Multiple Sclerosis Patients Treated With Epigallocatechin Gallate: Optical Coherence Tomography Results From the SUPREMES Study
por: Klumbies, Katharina, et al.
Publicado: (2021)

Low contrast visual acuity testing is associated with cognitive performance in multiple sclerosis: a cross-sectional pilot study
por: Wieder, Laura, et al.
Publicado: (2013)

Association Between Fatigue and Motor Exertion in Patients With Multiple Sclerosis—a Prospective Study
por: Drebinger, Daniel, et al.
Publicado: (2020)

Neural Processes of Psychological Stress and Relaxation Predict the Future Evolution of Quality of Life in Multiple Sclerosis
por: Meyer-Arndt, Lil, et al.
Publicado: (2021)

Epigallocatechin Gallate in Relapsing-Remitting Multiple Sclerosis: A Randomized, Placebo-Controlled Trial
por: Bellmann-Strobl, Judith, et al.
Publicado: (2021)

Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases
por: Koduah, Priscilla, et al.
Publicado: (2017)

Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study
por: Schmidt, Felix A., et al.
Publicado: (2020)

Altered Coupling of Psychological Relaxation and Regional Volume of Brain Reward Areas in Multiple Sclerosis
por: Wakonig, Katharina, et al.
Publicado: (2020)

Evaluation of the ‘ring sign’ and the ‘core sign’ as a magnetic resonance imaging marker of disease activity and progression in clinically isolated syndrome and early multiple sclerosis
por: Blindenbacher, Nelly, et al.
Publicado: (2020)

Fingolimod Therapy in Multiple Sclerosis Leads to the Enrichment of a Subpopulation of Aged NK Cells
por: Schwichtenberg, Svenja C., et al.
Publicado: (2021)

Association of a Marker of N-Acetylglucosamine With Progressive Multiple Sclerosis and Neurodegeneration
por: Brandt, Alexander U., et al.
Publicado: (2021)

Metabolic Changes in the Visual Cortex Are Linked to Retinal Nerve Fiber Layer Thinning in Multiple Sclerosis
por: Pfueller, Caspar F., et al.
Publicado: (2011)

7 Tesla MRI of Balo's concentric sclerosis versus multiple sclerosis lesions
por: Behrens, Janina R., et al.
Publicado: (2018)

MRI Markers and Functional Performance in Patients With CIS and MS: A Cross-Sectional Study
por: Rasche, Ludwig, et al.
Publicado: (2018)

Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial
por: Rosche, Berit, et al.
Publicado: (2013)

Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study
por: Rasche, Ludwig, et al.
Publicado: (2016)

Exploratory Investigation of Intestinal Function and Bacterial Translocation After Focal Cerebral Ischemia in the Mouse
por: Oyama, Naoki, et al.
Publicado: (2018)

Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation
por: Cooper, Graham, et al.
Publicado: (2021)

Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis
por: Gieß, René M., et al.
Publicado: (2017)

Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders
por: Asseyer, Susanna, et al.
Publicado: (2018)

Vision and Vision-Related Measures in Progressive Multiple Sclerosis
por: Backner, Yael, et al.
Publicado: (2019)

Vitamin D as a Risk Factor for Multiple Sclerosis: Immunoregulatory or Neuroprotective?
por: Gombash, Sara E., et al.
Publicado: (2022)

Central stress processing, T-cell responsivity to stress hormones and disease severity in multiple sclerosis
por: Brasanac, Jelena, et al.
Publicado: (2022)

Sleep Disorders Reduce Health-Related Quality of Life in Multiple Sclerosis (Nottingham Health Profile Data in Patients with Multiple Sclerosis)
por: Veauthier, Christian, et al.
Publicado: (2015)

Transient enlargement of brain ventricles during relapsing-remitting multiple sclerosis and experimental autoimmune encephalomyelitis
por: Millward, Jason M., et al.
Publicado: (2020)

Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica
por: Pasquier, Baptiste, et al.
Publicado: (2019)

Uncovering convolutional neural network decisions for diagnosing multiple sclerosis on conventional MRI using layer-wise relevance propagation
por: Eitel, Fabian, et al.
Publicado: (2019)

Temporal visual resolution and disease severity in MS
por: Ayadi, Noah, et al.
Publicado: (2018)

Poor Sleep in Multiple Sclerosis Correlates with Beck Depression Inventory Values, but Not with Polysomnographic Data
por: Veauthier, Christian, et al.
Publicado: (2016)

Blunted neural and psychological stress processing predicts future grey matter atrophy in multiple sclerosis
por: Meyer-Arndt, Lil, et al.
Publicado: (2020)

Fingolimod after a first unilateral episode of acute optic neuritis (MOVING) – preliminary results from a randomized, rater-blind, active-controlled, phase 2 trial
por: Albert, Christian, et al.
Publicado: (2020)

MRI Pattern Recognition in Multiple Sclerosis Normal-Appearing Brain Areas
por: Weygandt, Martin, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_qviklau1570ejp29e4a5lpm0ev